Douglas Beck
Director of Finance/CFO at Beyond Air Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Amir Avniel | M | 50 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 13 years |
Steven Lisi | M | 53 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 8 years |
Charles Casamento | M | 78 | 9 years | |
Maged Shenouda | M | 59 | 9 years | |
David Greenberg | M | 64 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 13 years |
Robert Carey | M | 65 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 5 years |
Michael Gaul | M | 70 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 4 years |
Ronald Bentsur | M | 58 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 9 years |
Duncan Fatkin | M | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 5 years |
Paul Kelly | M | 65 | 9 years | |
Asher Tal | M | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | - |
Martin Scott | M | 55 | - | |
Ali Ardakani | M | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | - |
Stephen L. Collins | M | - |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 17 years |
Erick Lucera | M | 57 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 7 years |
Rhona Shanker | F | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | - |
Yoori Lee | F | 51 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 6 years |
William Forbes | M | 62 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 6 years |
Frederick Montgomery | M | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | - |
Peter Senior | M | - | 3 years | |
Kori-Ann Taylor | F | - | 3 years | |
Douglas Larson | M | 53 | 3 years | |
Hannah Blau | F | - |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | - |
Timothy Papp | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michael D. Becker | M | 55 | 3 years | |
Brian L. Reach | M | 70 |
Henry Bros. Electronics, Inc. (New Jersey)
Henry Bros. Electronics, Inc. (New Jersey) Miscellaneous Commercial ServicesCommercial Services Henry Bros. Electronics, Inc. provides electronic security systems and services. The company was founded in 1989 and is headquartered in San Diego, CA. | - |
Stephen DiPalma | M | 66 | - | |
Shreeram N. Agharkar | M | 77 | 2 years | |
Eliseo Salinas | M | 69 | 1 years | |
Frederick Larcombe | M | 67 | 2 years | |
Pamela Bassett | M | - | 1 years | |
Joseph Truitt | M | 59 |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 2 years |
Kenneth Weaver | M | 69 | 7 years | |
Julie J. Chen | F | - | - | |
Jules Müsing | M | 76 | 2 years | |
Steven Ward | M | 64 |
Fairleigh Dickinson University
| 7 years |
Nabil M. Yazgi | M | 70 | 1 years | |
Ari Raved | M | 71 |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Beyond Air, Ltd. is a clinical-stage medical device and biopharmaceutical company engaging in the development of nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company was founded by Yossef Av-Gay, Amir Avniel, and David Greenberg in May 2011 and is headquartered in Rehovot, Israel. | 7 years |
Kulendiran Purushothaman | M | 60 | 1 years | |
Nicholas Aynilian | M | 60 |
Fairleigh Dickinson University
| 6 years |
Seymour Flug | M | 88 | 9 years | |
Louis S. Massad | M | 86 |
Henry Bros. Electronics, Inc. (New Jersey)
Henry Bros. Electronics, Inc. (New Jersey) Miscellaneous Commercial ServicesCommercial Services Henry Bros. Electronics, Inc. provides electronic security systems and services. The company was founded in 1989 and is headquartered in San Diego, CA. | 3 years |
Dennis Dwulet | M | - |
Fairleigh Dickinson University
| 2 years |
Stephen Leftly | M | - |
Fairleigh Dickinson University
| 2 years |
Stuart Mark Stern | M | - |
Fairleigh Dickinson University
| 4 years |
Gary Slodowski | M | - |
Fairleigh Dickinson University
| 4 years |
Anthony C. LaBrosciano | M | 80 |
Fairleigh Dickinson University
| 2 years |
Brent S. Peckis | M | - |
Fairleigh Dickinson University
| 4 years |
Jason Bablak | M | - |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 5 years |
Ann S. Kraus | F | - |
Fairleigh Dickinson University
| 2 years |
James C. McKenna | M | - |
Fairleigh Dickinson University
| 4 years |
Michael Steven Maglio | M | - |
Fairleigh Dickinson University
| 4 years |
Savas Tsivicos | M | - |
Fairleigh Dickinson University
| 4 years |
Vassos Russ Chrysanthou | M | - |
Fairleigh Dickinson University
| 4 years |
John Formisano | M | - |
Fairleigh Dickinson University
| 3 years |
Rory Zirpolo | M | - |
Fairleigh Dickinson University
| 4 years |
John N. DiBlanda | M | - |
Fairleigh Dickinson University
| 4 years |
Alan R. Dietrich | M | - |
Fairleigh Dickinson University
| 1 years |
Anna Gözübüyükoglu | F | 65 |
Fairleigh Dickinson University
| 4 years |
Robert Sheroff | M | 69 |
Fairleigh Dickinson University
| 5 years |
Christopher W. James | M | - | - | |
Glenn Edward Stephenson | M | 61 |
Fairleigh Dickinson University
| 4 years |
Larry Fox | M | - |
Fairleigh Dickinson University
| 4 years |
Kenneth F. Fagan | M | 70 |
Fairleigh Dickinson University
| 2 years |
Joe Bonaccorso | M | 60 |
Fairleigh Dickinson University
| 4 years |
James Aloysious Reddington | M | - |
Fairleigh Dickinson University
| 3 years |
Gary Balkema | M | 69 |
Fairleigh Dickinson University
| 2 years |
Ron Johnson | M | - |
Fairleigh Dickinson University
| 2 years |
Paul Firuta | M | 58 |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 2 years |
Dave Powers | M | - |
Fairleigh Dickinson University
| 4 years |
Barry Hollander | M | 67 |
Fairleigh Dickinson University
| 4 years |
Joseph N. Seibert | M | - |
Fairleigh Dickinson University
| 4 years |
Jerome R. Mahoney | M | 64 |
Fairleigh Dickinson University
| 4 years |
Kerry A. Guthrie | M | 66 |
Fairleigh Dickinson University
| 2 years |
Eric Richman | M | 63 |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 4 years |
Patrick A. Cozza | M | 68 |
Fairleigh Dickinson University
| 2 years |
Bruce Paparone | M | 62 |
Fairleigh Dickinson University
| 4 years |
Silvana Costa Manning | F | 70 |
Fairleigh Dickinson University
| 1 years |
Martin M. Coyne | M | 74 |
Fairleigh Dickinson University
| 2 years |
Bill Keefe | M | 65 |
Fairleigh Dickinson University
| 4 years |
Robert P. Heller | M | 62 |
Fairleigh Dickinson University
| 4 years |
Glenn Sblendorio | M | 68 |
Fairleigh Dickinson University
| 2 years |
Michael David Jamison | M | - |
Fairleigh Dickinson University
| 2 years |
Michael James | M | 65 |
Fairleigh Dickinson University
| 4 years |
Nelson A. Garcia | M | 63 |
Fairleigh Dickinson University
| 4 years |
George Ugras | M | - |
Fairleigh Dickinson University
| 4 years |
Jeong-Eun Hyun | F | 69 |
Fairleigh Dickinson University
| 1 years |
Dov Elefant | M | 56 |
Lev Pharmaceuticals, Inc.
Lev Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lev Pharmaceuticals, Inc. develops and commercializes therapeutic products for the treatment of inflammatory diseases. It researches a series of drugs to fight both edema and heart attacks. The company is located in New York. | 2 years |
Se-Ho Chun | M | 68 |
Fairleigh Dickinson University
| 2 years |
John S. Gregorits | M | 69 |
Fairleigh Dickinson University
| 1 years |
Kenneth F. Tempero | M | - |
Fairleigh Dickinson University
| 2 years |
Michael Mendes | M | - |
Fairleigh Dickinson University
| 4 years |
Robert J. Staab | M | - |
Fairleigh Dickinson University
| 2 years |
Michael W. O'Gorman | M | 68 |
Fairleigh Dickinson University
| 2 years |
Kimberly D. C. Trapp | F | 65 |
Fairleigh Dickinson University
| 1 years |
Richard Frederick Schmidt | M | - |
Fairleigh Dickinson University
| 2 years |
William J. Rose | M | - |
Fairleigh Dickinson University
| 2 years |
John Zaleskie | M | - |
Fairleigh Dickinson University
| 4 years |
Michael S. Solomon | M | 63 |
Fairleigh Dickinson University
| 4 years |
Yoni Pasternak | M | 66 |
Fairleigh Dickinson University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 89 | 89.00% |
Israel | 16 | 16.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Beck
- Personal Network